Hers is a telehealth platform from the same parent company as Hims, focused on women's health needs including skincare, hair care, mental health, and sexual wellness. It offers virtual consultations with licensed providers and prescription delivery, addressing health topics women may prefer to discuss remotely.
Hers competes in women's digital health alongside Nurx, The Pill Club, and broader telehealth platforms like Teladoc. The women's health market is less consolidated than men's, with many niche players addressing specific conditions from fertility to menopause.
Focused on reproductive health with birth control delivery and at-home STI testing. Strong positioning in a specific women's health vertical.
Enterprise-focused women's and family health platform covering fertility, pregnancy, and postpartum. B2B model through employer benefits.
Gender-inclusive digital health platform with women's health offerings alongside its broader clinical scope. Competes on breadth of services.
Women's health spans many conditions (fertility, menopause, skincare, mental health) each with specialized competitors. Hers's generalist positioning risks being outperformed by focused players in each vertical.
As a sibling brand to Hims, Hers must establish its own identity and trust. Women's health requires different clinical sensitivity and expertise than the men's health playbook Hims pioneered.
Enterprise women's health benefits are growing, with Maven and Progyny leading the B2B segment. Hers could expand into employer partnerships but faces established players with clinical credibility.
Hers competes with Nurx (reproductive health), Maven Clinic (fertility and family), The Pill Club (birth control), and general telehealth platforms. Specialized players in skincare and mental health also overlap.
Hers covers broader women's health including skincare and mental wellness, while Nurx focuses specifically on birth control, STI testing, and reproductive health. Nurx has deeper expertise in its niche.
Yes, Hers is operated by Hims & Hers Health, Inc. (NYSE: HIMS). The platforms share infrastructure but target different demographics with gender-specific health offerings and marketing.